51 employees
Aptamer Group develop DNA and RNA nucleic acid aptamers for use in R&D, biomarker discovery, diagnostics or therapeutic developments.
2008
$2.2M
from 1 investors over 1 rounds
Aptamer Group raised $2.2M on June 29, 2018
Investors: Meneldor